From Raquel Martins, President of Abranghe – Angioedema Hereditário Brasil, HAE International has received the very good news that Takhzyro (Lanadelumab) is now approved in Brazil for the treatment of HAE. The approval comes from the Brazilian Health Regulatory Agency (Anvisa), the coordinator of the Brazilian Health Regulatory System.
25-28 September 2019 Abranghe participated in and promoted HAE at the XLVI Brazilian Congress of Allergy and Immunology in Florianópolis.
18 October 2019 Abranghe took part in the III Ibero-American Congress of Rare Diseases in Brasilia. Among the speakers were Dr. Teresa Caballero Molina from Madrid, Spain and Dr. Solange Valle from Rio de Janeiro, Brazil.
This fall has also brought the release of the book “Doutor, eu tengo Angioedema Hereditario” – or in English “Doctor, I have HAE”.